Current Directions in Systemic Therapy for Gastrointestinal Stromal Tumors

被引：6
作者：
Chugh, Rashmi [1 ]
机构：
[1] Univ Michigan, Sch Med, Div Hematol Oncol, Ann Arbor, MI 48109 USA
来源：
CURRENT PROBLEMS IN CANCER | 2011年 / 35卷 / 05期
关键词：
POSITRON-EMISSION-TOMOGRAPHY; IMATINIB PLASMA-LEVELS; CHRONIC MYELOID-LEUKEMIA; TYROSINE KINASE; CLINICAL BENEFIT; EARLY PREDICTION; DOSE IMATINIB; SOFT-TISSUE; MESYLATE; PHARMACOKINETICS;
D O I：
10.1016/j.currproblcancer.2011.10.001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：255 / 270
页数：16
相关论文
共 44 条
[1]   We should desist using RECIST, at least in GIST [J].
Benjamin, Robert S. ;
Choi, Haesun ;
Macapinlac, Homer A. ;
Burgess, Michael A. ;
Patel, Shreyaskumar R. ;
Chen, Lei L. ;
Podoloff, Donald A. ;
Charnsangavej, Chuslip .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (13) :1760-1764
[2]   Efficacy and safety of motesanib, an oral inhibitor of VEGF, PDGF, and Kit receptors, in patients with imatinib-resistant gastrointestinal stromal tumors [J].
Benjamin, Robert S. ;
Schoffski, Patrick ;
Hartmann, Joerg Thomas ;
Van Oosterom, Allan ;
Binh Nguyen Bui ;
Duyster, Justus ;
Schuetze, Scott ;
Blay, Jean-Yves ;
Reichardt, Peter ;
Rosen, Lee S. ;
Skubitz, Keith ;
McCoy, Sheryl ;
Sun, Yu-Nien ;
Stepan, Daniel E. ;
Baker, Laurence .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (01) :69-77
[3]   Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033 [J].
Blanke, Charles D. ;
Rankin, Cathryn ;
Demetri, George D. ;
Ryan, Christopher W. ;
von Mehren, Margaret ;
Benjamin, Robert S. ;
Raymond, A. Kevin ;
Bramwell, Vivien H. C. ;
Baker, Laurence H. ;
Maki, Robert G. ;
Tanaka, Michael ;
Hecht, J. Randolph ;
Heinrich, Michael C. ;
Fletcher, Christopher D. M. ;
Crowley, John J. ;
Borden, Ernest C. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (04) :626-632
[4]   Nilotinib: A Novel, Selective Tyrosine Kinase Inhibitor [J].
Blay, Jean-Yves ;
von Mehren, Margaret .
SEMINARS IN ONCOLOGY, 2011, 38 (02) :S3-S9
[5]   Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial [J].
Blesius, Aurore ;
Cassier, Philippe A. ;
Bertucci, Francois ;
Fayette, Jerome ;
Ray-Coquard, Isabelle ;
Bui, Binh ;
Adenis, Antoine ;
Rios, Maria ;
Cupissol, Didier ;
Perol, David ;
Blay, Jean-Yves ;
Le Cesne, Axel .
BMC CANCER, 2011, 11
[6]   Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: Proposal of new computed tomography response criteria [J].
Choi, Haesun ;
Charnsangavej, Chuslip ;
Faria, Silvana C. ;
Macapinlac, Homer A. ;
Burgess, Michael A. ;
Patel, Shreyaskumar R. ;
Chen, Lei L. ;
Podoloff, Donald A. ;
Benjamin, Robert S. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (13) :1753-1759
[7]   KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours [J].
Debiec-Rychter, Maria ;
Sciot, Raf ;
Le Cesne, Axel ;
Schlemmer, Marcus ;
Hohenberger, Peter ;
van Oosterom, Allan T. ;
Blay, Jean-Yves ;
Leyvraz, Serge ;
Stul, Michel ;
Casali, Paolo G. ;
Zalcberg, John ;
Verweij, Jaap ;
Van Glabbeke, Martine ;
Hagemeijer, Anne ;
Judson, Ian .
EUROPEAN JOURNAL OF CANCER, 2006, 42 (08) :1093-1103
[8]   Pharmacokinetic-pharmacodynamic relationships of imatinib and its main metabolite in patients with advanced gastrointestinal stromal tumors [J].
Delbaldo, Catherine ;
Chatelut, Etienne ;
Re, Micheline ;
Deroussent, Alain ;
Seronie-Vivien, Sophie ;
Jambu, Aurore ;
Berthaud, Patrice ;
Le Cesne, Axel ;
Blay, Jean-Yves ;
Vassal, Gilles .
CLINICAL CANCER RESEARCH, 2006, 12 (20) :6073-6078
[9]   Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial [J].
DeMatteo, Ronald P. ;
Ballman, Karla V. ;
Antonescu, Cristina R. ;
Maki, Robert G. ;
Pisters, Peter W. T. ;
Demetri, George D. ;
Blackstein, Martin E. ;
Blanke, Charles D. ;
von Mehren, Margaret ;
Brennan, Murray F. ;
Patel, Shreyaskumar ;
McCarter, Martin D. ;
Polikoff, Jonathan A. ;
Tan, Benjamin R. ;
Owzar, Kouros .
LANCET, 2009, 373 (9669) :1097-1104
[10]   Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial [J].
Demetri, George D. ;
van Oosterom, Allan T. ;
Garrett, Christopher R. ;
Blackstein, Martin E. ;
Shah, Manisha H. ;
Verweij, Jaap ;
McArthur, Grant ;
Judson, Ian R. ;
Heinrich, Michael C. ;
Morgan, Jeffrey A. ;
Desai, Jayesh ;
D Fletcher, Christopher ;
George, Suzanne ;
Bello, Carlo L. ;
Huang, Xin ;
Baum, Charles M. ;
Casali, Paolo G. .
LANCET, 2006, 368 (9544) :1329-1338
12345